| Literature DB >> 33119623 |
Lionel De Alencastro1, Isabella Locatelli1, Carole Clair1, Mark H Ebell2, Nicolas Senn1.
Abstract
BACKGROUND: Medical decision-making relies partly on the probability of disease. Current recommendations for the management of common diseases are based increasingly on scores that use arbitrary probability thresholds.Entities:
Mesh:
Year: 2020 PMID: 33119623 PMCID: PMC7595298 DOI: 10.1371/journal.pone.0241210
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Path through the questionnaire.
PT: True probability, PE: Estimated probability. A: compares the clinical decisions of the GPs to the true probabilities of the vignettes (PT). B: compares the clinical decisions of the GPs to their estimation of the probabilities (PE). C: compares the estimated probability (PE) of the GPs to the true probability (PT) of the vignette.
Baseline characteristics of the participants.
| Total | Switzerland | USA | |
|---|---|---|---|
| Women, N (%) | 95 (33.93%) | 67 (34.54%) | 28 (32.56%) |
| Age, mean (SD) | 48.86 (12.06) | 50.20 (11.98) | 45.84 (11.74) |
| Work in a practice, N (%) | 220 (78.57%) | 146 (75.26%) | 74 (86.05%) |
| Imaging nearby, N (%) | 114 (40.71%) | 77 (39.69%) | 37 (43.02%) |
* n = 280.
Concordance between physician decision (symptomatic, investigation or treatment) and true, respectively estimated probability of disease (low, medium or high).
| Symptomatic | Investigation | Treatment | Symptomatic | Investigation | Treatment | ||
| Low | 167 | 20 | 1 | 172 | 18 | 1 | |
| Medium | 38 | 94 | 63 | 46 | 134 | 8 | |
| High | 5 | 57 | 129 | 7 | 127 | 61 | |
| 0.74 (0.70–0.78) | 0.66 (0.62–0.71) | ||||||
| Symptomatic | Investigation | Treatment | Symptomatic | Investigation | Treatment | ||
| Low | 194 | 97 | 27 | 186 | 14 | 0 | |
| Medium | 3 | 54 | 80 | 23 | 92 | 0 | |
| High | 1 | 20 | 83 | 5 | 171 | 70 | |
| 0.61 (0.56–0.66) | 0.70 (0.66–0.73) | ||||||
aSymptomatic = symptomatic management only with no testing or treatment.
bInvestigation = further investigation recommended.
cTreatment = treatment should be initiated.
Concordance between estimated and true probability.
| 3 | 0 | 0 | 0 | 0 | |||
| 87 | 0 | 0 | 0 | 0 | |||
| 48 | 28 | 2 | 4 | 7 | |||
| 42 | 25 | 7 | 10 | 8 | |||
| 11 | 24 | 10 | 0 | 24 | |||
| 12 | 16 | 9 | 2 | 19 | |||
| 61% | 29% | 10% | |||||
| 54 | 3 | 0 | 0 | 0 | |||
| 6 | 10 | 4 | 3 | 2 | |||
| 5 | 15 | 18 | 17 | 19 | |||
| 4 | 11 | 14 | 28 | 10 | |||
| 0 | 1 | 2 | 9 | 49 | |||
| 0 | 1 | 3 | 9 | 33 | |||
| 22% | 39% | 39% | |||||
Fig 2Test and treatment thresholds for appendicitis and pharyngitis (obtained as equal to 0.5 the probability of not ruling out (test threshold) and treating (treatment threshold) estimated according to model (1).
Points represent empirical frequencies of decisions according to the true disease probability). Test: test threshold, Treat: treatment threshold.
Test and treatment thresholds for different subgroup populations.
| Appendicitis | Pharyngitis | |||||
|---|---|---|---|---|---|---|
| Estimate (95%CI) | p-value of the difference | Estimate (95%CI) | p-value of the difference | |||
| Test threshold | Country | CH | 54.1 (49.9–56.6) | 16.5 (13.9–19.5) | 0.708 | |
| USA | 47.7 (40.6–52.2) | 15.6 (11.7–20.0) | ||||
| Sex physician | Male | 53.6 (49.1–56.2) | 0.051 | 16.3 (13.6–19.6) | 0.780 | |
| Female | 49.4 (42.7–53.5) | 15.7 (12.2–19.5) | ||||
| Age physician | ≤ 50 | 53.1 (48.6–55.9) | 0.307 | 14.5 (11.8–17.6) | 0.121 | |
| > 50 | 51.2 (45.2–54.6) | 17.9 (14.6–22.0) | ||||
| Sex patient | Male | 52.2 (46.8–55.4) | 0.899 | 17.6 (14.7–21.3) | 0.147 | |
| Female | 52.4 (47.5–55.4) | 14.5 (11.5–18.0) | ||||
| Treatment threshold | Country | CH | 67.5 (65.2–71.3) | 100 (70.4–100) | ||
| USA | 73.7 (68.4–82.7) | 61.1 (42.3–100) | ||||
| Sex physician | Male | 68.0 (65.5–72.1) | 0.256 | 87.4 (58.6–100) | 0.931 | |
| Female | 70.5 (66.5–77.0) | 86.8 (58.6–100) | ||||
| Age physician | ≤ 50 | 70.7 (67.4–76.6) | 78.1 (53.0–100) | |||
| > 50 | 66.8 (64.2–70.4) | 99.3 (66.5–100) | ||||
| Sex patient | Male | 67.6 (64.7–72.2) | 86.9 (59–100) | 0.832 | ||
| Female | 71.4 (67.7–78.1) | 88.1 (59.6–100) | ||||